Radiochemistry

Bayer and Bicycle Therapeutics have entered into a strategic collaboration agreement to discover, develop, manufacture, and commercialise Bicycle radioconjugates for multiple oncology targets. Bicyclic peptides are peptides consisting of 9-20 amino acids that can be synthetically manufactured and bind to targets with high affinity and selectivity, affording high tumour penetration and fast excretion from healthy […]

Medicines Discovery Catapult (MDC) has relaunched radiochemistry at the Wolfson Molecular Imaging Centre (WMIC) at the University of Manchester, UK. The facility, which was closed in 2020, includes the multi-million pound ‘Cyclotron’, one of only a few in the UK. It will supply radio-chemicals to drug discovery biotechs and academics, reportedly increasing the UK’s potential […]